Cutaneous Radiation Injuries: Models, Assessment and Treatments
Open Access
- 28 August 2020
- journal article
- editorial
- Published by Radiation Research Society in Radiation Research
- Vol. 194 (3), 310-313
- https://doi.org/10.1667/rade-20-00132.1
Abstract
Multiple cases of human exposure to radiation have been documented from the atomic bombings, nuclear power plant disasters and other industrial and medical accidents. Many of these exposures have led to pronounced cutaneous radiation injury (CRI), which played a significant role in the progression of damage and survivability of the radiation exposure and led to a lifetime of pain and scarring. Documentation of CRI from routine clinical radiotherapy and diagnostic procedures has also provided valuable information about the natural history of the injury. In response to the threat of a radiological or nuclear incident, the U.S. Department of Health and Human Services tasked the National Institute of Allergy and Infectious Diseases (NIAID) with identifying and funding early- to mid-stage medical countermeasure (MCM) development to treat radiation-induced injuries. Although there are now products to treat radiation-induced bone marrow damage, there are still no approved products specific for the treatment of CRI. To accurately assess severity of CRI and determine efficacy of different treatments, animal models must be developed that simulate what is seen in humans. It is also important to understand techniques used in other clinical indications to accurately assess the extent of skin injury and progression of healing. For these reasons, the NIAID partnered with the Food and Drug Administration (FDA)2 and the Biomedical Advanced Research and Development Authority (BARDA) to identify state-of-the-art methods in assessment of skin injuries, explore animal models to better understand radiation-induced cutaneous damage and explore treatment approaches. A two-day workshop was convened in Rockville, MD on May 6 and 7, 2019, highlighting talks from 28 subject matter experts across five scientific sessions, and from this workshop a report was generated (1). This commentary provides a brief overview of the data presented at the workshop, and the key points that were considered during the discussion sessions that were held throughout the meeting. A more complete background and discussion of the workshop are available in the full report.Keywords
This publication has 30 references indexed in Scilit:
- Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelinesAnnals of Oncology, 2011
- Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancerSupportive Care in Cancer, 2011
- COMBINED INJURY: FACTORS WITH POTENTIAL TO IMPACT RADIATION DOSE ASSESSMENTSHealth Physics, 2010
- Radiation-induced skin injury in the animal model of scleroderma: implications for post-radiotherapy fibrosisRadiation Oncology, 2008
- Radiologic and nuclear events: the METREPOL severity of effect grading systemBlood, 2008
- Thrombin peptide Chrysalin® stimulates healing of diabetic foot ulcers in a placebo‐controlled phase I/II studyWound Repair and Regeneration, 2007
- Randomized, Placebo-Controlled Trial of Combined Pentoxifylline and Tocopherol for Regression of Superficial Radiation-Induced FibrosisJournal of Clinical Oncology, 2003
- Effect of low-dose radiation on mouse dermal tissue using wound strength as an endpointInternational Journal of Radiation Biology, 1997
- A Radiation Accident at an Industrial Accelerator FacilityHealth Physics, 1993
- A Guinea-Pig Model in Burn ResearchEuropean Surgical Research, 1980